COVID-19 incidence and hospitalization in routine clinical practice among COPD patients in England in 2020
K. Rothnie (London, United Kingdom), T. Tritton (Bollington, United Kingdom), X. Han (Collegeville, United States), T. Holbrook (Bollington, United Kingdom), B. Numbere (London, United Kingdom), A. Ford (Bollington, United Kingdom), L. Massey (Bollington, United Kingdom), Q. Fu (Collegeville, United States), F. Hutchinson (Dublin, Ireland), H. Birch (Brentford, United Kingdom), D. Leather (London, United Kingdom), R. Sharma (London, United Kingdom), C. Compton (London, United Kingdom), A. Ismaila (Collegeville, United States)
Source: International Congress 2022 – Exacerbations in COPD: biomarkers and management
Session: Exacerbations in COPD: biomarkers and management
Session type: Thematic Poster
Number: 200
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Rothnie (London, United Kingdom), T. Tritton (Bollington, United Kingdom), X. Han (Collegeville, United States), T. Holbrook (Bollington, United Kingdom), B. Numbere (London, United Kingdom), A. Ford (Bollington, United Kingdom), L. Massey (Bollington, United Kingdom), Q. Fu (Collegeville, United States), F. Hutchinson (Dublin, Ireland), H. Birch (Brentford, United Kingdom), D. Leather (London, United Kingdom), R. Sharma (London, United Kingdom), C. Compton (London, United Kingdom), A. Ismaila (Collegeville, United States). COVID-19 incidence and hospitalization in routine clinical practice among COPD patients in England in 2020. 200
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|